Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Prestige Consumer Healthcare Inc. (PBH)Equibles does not estimate personal net worth.
Get an email with a short summary when Prestige Consumer Healthcare Inc. publishes a filing, an earnings call transcript or a press release.
Get PBH alertsPhil Terpolilli is recorded as Head of Investor Relations at Prestige Consumer Healthcare Inc. (PBH). Phil Terpolilli has spoken on 22 earnings calls and 4 other investor events across 1 company, most recently for Prestige Consumer Healthcare Inc. on August 12, 2026. Prestige Consumer Healthcare Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Prestige Consumer Healthcare Inc. includes Ronald M. Lombardi (CEO and Board Member), Christine Sacco (CFO and COO), William C. P’Pool (General Counsel) and 7 others.
“So you're exactly right, Vickr. we see the same thing you do, which is on a global basis, consumer health care is quite fragmented when you look at it in comparison to other sections of the grocery store and the pharmacy.”
“So from a very high level, you're exactly right, Susan. We operate with a very strong financial profile that has very strong free cash flow conversion. And that's consistent over time as well.”
“On the call with me are Rahm Lombardi, our Chairman, President, and CEO, and Chris Sacco, our CFO and COO. On today's call, we'll review our first quarter fiscal 2027 results, discuss our increased full-year outlook, and then take questions from analysts.”
“It's in many ways similar to how we think about many of the crown jewels of our portfolio, where they represent the category and have a lot of great growth opportunities.”
“On the call with me are Ron Lombardi, our Chairman, President, and CEO, and Christine Sacco, our CFO and COO. On today's call, we're gonna review our fiscal 2026 results, discuss our fiscal 2027 and longer term outlook, and then take questions from analysts.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations